Julio J Lopez-Picazo

Summary

Country: Spain

Publications

  1. ncbi [The assessment process and variability in the conferences of Spanish Society of Quality in Healthcare]
    J J López-Picazo Ferrer
    Área I Murcia Oeste, Hospital Universitario Virgen de la Arrixaca, Murcia, España Electronic address
    Rev Calid Asist 27:351-7. 2012
  2. ncbi [Prescription of drugs in family medicine: on the trail of efficiency]
    J J López-Picazo Ferrer
    Unidad de Calidad, Gerencia de Atencion Primaria de Murcia, Murcia, Spain
    Aten Primaria 34:178-85. 2004
  3. ncbi [Using information technology to improve drug safety in primary care]
    J J López-Picazo
    Gerencia de Atencion Primaria de Murcia, Servicio Murciano de Salud, Murcia, Espana
    Rev Calid Asist 25:12-20. 2010
  4. ncbi Prevalence and typology of potential drug interactions occurring in primary care patients
    Julio J Lopez-Picazo
    Gerencia de Atencion Primaria de Murcia, Murcia Health Service, Spain
    Eur J Gen Pract 16:92-9. 2010
  5. ncbi [A hazard scale for severe interactions: a tool for establishing prioritising strategies to improve the safety of the prescription in family medicine]
    Julio J Lopez-Picazo
    Medico de Familia, Dirección General de Asistencia Sanitaria, Servicio Murciano de Salud, Murcia, Espana
    Aten Primaria 43:254-62. 2011
  6. ncbi A randomized trial of the effectiveness and efficiency of interventions to reduce potential drug interactions in primary care
    Julio J Lopez-Picazo
    Murcia Health Service, Murcia Health Area, Murcia, Spain
    Am J Med Qual 26:145-53. 2011

Collaborators

  • Juan C Ruiz
  • E Salas Martín
  • J J López-Picazo Ferrer
  • M Alcaráz Quiñonero
  • F Sanchez Rodriguez
  • J A Sanz Moreno
  • J F Sánchez Ruiz
  • V Rausell Rausell

Detail Information

Publications6

  1. ncbi [The assessment process and variability in the conferences of Spanish Society of Quality in Healthcare]
    J J López-Picazo Ferrer
    Área I Murcia Oeste, Hospital Universitario Virgen de la Arrixaca, Murcia, España Electronic address
    Rev Calid Asist 27:351-7. 2012
    ..To describe the abstracts assessment process in the 2011 Conference of the Spanish Society for Quality in Health Care, focusing on the procedures adopted to control the interobserver variability...
  2. ncbi [Prescription of drugs in family medicine: on the trail of efficiency]
    J J López-Picazo Ferrer
    Unidad de Calidad, Gerencia de Atencion Primaria de Murcia, Murcia, Spain
    Aten Primaria 34:178-85. 2004
    ..To analyse the effect of various factors on the efficiency of drug prescription by general practitioners (GPs)...
  3. ncbi [Using information technology to improve drug safety in primary care]
    J J López-Picazo
    Gerencia de Atencion Primaria de Murcia, Servicio Murciano de Salud, Murcia, Espana
    Rev Calid Asist 25:12-20. 2010
    ..To help family doctors to detect and prevent problems related to drug-drug interactions in order to attain a higher quality prescription and an improvement in patient safety...
  4. ncbi Prevalence and typology of potential drug interactions occurring in primary care patients
    Julio J Lopez-Picazo
    Gerencia de Atencion Primaria de Murcia, Murcia Health Service, Spain
    Eur J Gen Pract 16:92-9. 2010
    ..To investigate the prevalence and types of potential drug interactions in primary care patients to detect risky prescriptions as an essential condition to design intervention policies leading to an improvement in patient safety...
  5. ncbi [A hazard scale for severe interactions: a tool for establishing prioritising strategies to improve the safety of the prescription in family medicine]
    Julio J Lopez-Picazo
    Medico de Familia, Dirección General de Asistencia Sanitaria, Servicio Murciano de Salud, Murcia, Espana
    Aten Primaria 43:254-62. 2011
    ..To effectively locate the drugs most implicated in severe interactions as a basis of designing actions to improve patient safety in Primary Care...
  6. ncbi A randomized trial of the effectiveness and efficiency of interventions to reduce potential drug interactions in primary care
    Julio J Lopez-Picazo
    Murcia Health Service, Murcia Health Area, Murcia, Spain
    Am J Med Qual 26:145-53. 2011
    ..001). Incremental cost was higher in the face-to-face group (69.4€ vs 50.7€); cost-effectiveness results were slightly better in the session group (4.2€ vs 4.5€)...